## SNPS: Synopsys, Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.0% in lower entry zone (3.0-6.0%), top quartile (88th pct) cross-sectional ranking. Caution: MRS_5 (-0.2%) diverging from MRS_10, watch for reversal. Outperforming sector by 2.7%. Caution: momentum weakening (-6.1% MRS).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($436.73)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Levi & Korsinsky Notifies Synopsys, Inc. (SNPS) Shareholders of Class Action Lawsuit and December 30, 2025 Deadline**
- Source: CBS 42 | 20251207T160808 | Neutral | Relevance: 99%
-  Levi & Korsinsky LLP has announced a class action lawsuit against Synopsys, Inc. (NASDAQ: SNPS) on behalf of shareholders who suffered losses between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys made misleading statements regarding the financial impact of increased customization for AI customers on its Design IP business. Shareholders affected by these alleged securities frauds have until December 30, 2025, to seek a recovery without cost or obligation.

**2. SNPS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Synopsys, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!**
- Source: WRIC ABC 8News | 20251207T120857 | Neutral | Relevance: 99%
-  Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Synopsys, Inc. on behalf of investors who purchased securities between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys made materially false and misleading statements regarding the impact of its focus on AI customers on its Design IP business and financial results. Investors who suffered losses have until December 30, 2025, to request to be appointed as lead plaintiff.

**3. SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit**
- Source: FOX40 News | 20251207T110857 | Neutral | Relevance: 99%
-  The Rosen Law Firm is reminding purchasers of Synopsys, Inc. (NASDAQ: SNPS) securities who bought between December 4, 2024, and September 9, 2025, that the lead plaintiff deadline for a securities fraud lawsuit is December 30, 2025. The lawsuit alleges that Synopsys made materially false and misleading statements regarding its business operations, particularly concerning the impact of increased focus on AI customers on its Design IP business economics. Investors who suffered losses are encouraged to contact the Rosen Law Firm to explore their options to join the class action.

**4. SNPS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Synopsys, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!**
- Source: WSYR | 20251207T120855 | Neutral | Relevance: 99%
-  Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Synopsys, Inc. (NASDAQ: SNPS) on behalf of investors who purchased securities between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys made misleading statements regarding the financial impact of its increased focus on AI customers and related customization on its Design IP business. Investors with substantial losses are encouraged to seek lead plaintiff status by December 30, 2025.

**5. SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit with the Schall Law Firm**
- Source: Morningstar | 20251208T070841 | Neutral | Relevance: 99%
-  The Schall Law Firm has announced a class action lawsuit against Synopsys, Inc. (NASDAQ: SNPS) for alleged securities fraud, encouraging investors who purchased the company's securities between December 4, 2024, and September 9, 2025, to join before December 30, 2025. The lawsuit claims Synopsys made false and misleading statements, particularly regarding the negative impact of its focus on AI customers on its Design IP business. Investors are invited to contact the firm to discuss their rights and potentially recover losses.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Rosenblatt | $560 | $605 | -7% |
| 2025-12-08 | B of A Securiti | $500 | $525 | -5% |
| 2025-12-03 | Keybanc | $575 | $590 | -3% |
| 2025-11-25 | Wells Fargo | $445 | $550 | -19% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Rosenblatt | up | Buy |
| 2025-12-08 | B of A Securiti | up | Neutral |
| 2025-12-03 | Keybanc | main | Overweight |
| 2025-11-25 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 5 ($0.69M) |
| Sells | 3 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+20.7%)
- Blackrock Inc.: 8.2% (+18.5%)
- State Street Corpora: 4.7% (+20.6%)
- Capital World Invest: 4.0% (-3.7%)
- FMR, LLC: 3.1% (+47.5%)

### Key Risks

1. Valuation stretched: PEG 6.1x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 6.11 signals overvaluation risk, limited margin of safety. Forward P/E 33.1x stretched relative to 9% growth. Quality metrics strong (margin 31%). Revenue growth strong at 37% YoY. Analyst sentiment negative (4 target cuts vs 0 raises). Insider buying signal ($0.7M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $88.8B |
| Beta | 1.15 |
| 52W Range | $365.74 - $651.73 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.11 |
| Forward P/E | 33.1 |
| Current P/E | 36.3 |
| YoY Growth | 9.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 10.1% to 4.0% (-6.1% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 88th percentile. MRS_5 (-0.2%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.95x), long-term trend not supportive. MACD histogram positive (9.58), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.02% (CS: 89) | Strong |
| RSI_14 | 67.2 | Neutral |
| MACD Histogram | 9.58 | Bullish |
| vs SMA20 | 1.114x | Above |
| vs SMA50 | 1.064x | Above |
| vs SMA200 | 0.954x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $465.85
- **Stop Loss:** $436.73 (6.3% risk)
- **Target:** $509.53 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 41
- **Position Value:** $19,099.85
- **Portfolio %:** 19.10%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2025-12-10 (Est: $2.88)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.75 | $3.39 | -9.5% |
| 2025Q2 | $3.40 | $3.67 | +8.0% |
| 2025Q1 | $2.79 | $3.03 | +8.6% |
| 2024Q4 | $3.30 | $3.40 | +3.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*